{"id":"W4416968887","doi":"10.1182/bloodadvances.2025018079","title":"Consensus recommendations from the 2024 International Follicular Lymphoma Scientific Workshop","year":2025,"lang":"en","type":"article","venue":"Blood Advances","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia; Princess Margaret Cancer Centre","funders":"National Cancer Institute; Pharmacyclics; Genentech; National Institutes of Health; Incyte; Gilead Sciences; Regeneron Pharmaceuticals; Leukemia and Lymphoma Society; Ipsen; BeiGene; Daiichi Sankyo Europe; Sanofi; Pfizer; National Institute of Allergy and Infectious Diseases; MorphoSys; Celgene; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Follicular lymphoma; Lymphoma; Context (archaeology); Clinical trial; Disease; Chemotherapy; Follicular phase","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009109508,0.0001053542,0.0001373027,0.00006050916,0.0002396724,0.0001093338,0.0001363647,0.00002914887,0.0002842805],"category_scores_gemma":[0.0001629048,0.00006656875,0.00009581092,0.0002679432,0.0001214048,0.00005508551,0.00006081322,0.00003833472,0.00006414628],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006047059,"about_ca_system_score_gemma":0.000135201,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005010746,"about_ca_topic_score_gemma":0.000143049,"domain_scores_codex":[0.9991912,0.00002748205,0.0001870441,0.0002820325,0.0001792639,0.0001329384],"domain_scores_gemma":[0.9990637,0.0004418905,0.00005427191,0.0003059267,0.00008988199,0.00004427987],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001081299,0.002108052,0.2618988,0.00002062309,0.001516992,0.0001341396,0.0002834123,0.00001864509,0.0004949369,0.006251741,0.1696183,0.5575463],"study_design_scores_gemma":[0.002947068,0.00002300228,0.08614402,0.0002984017,0.0004052604,0.00001572773,0.0004508904,0.00006586391,0.004403742,0.001876107,0.9032895,0.00008043285],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8306094,0.03081185,0.00008439617,0.1037406,0.006030916,0.0006041845,0.000221475,0.0001017495,0.02779543],"genre_scores_gemma":[0.9781297,0.0009419307,0.002762715,0.001784887,0.000236925,0.0001352376,0.0002682455,0.000008715646,0.01573163],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7336712,"threshold_uncertainty_score":0.3112672,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01563828593378401,"score_gpt":0.3053785913689192,"score_spread":0.2897403054351352,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}